Skip to content

Ck-Mb CK4043

by Randox Laboratories, Ltd.

Ck-Mb CK4043 is a Class II device made by Randox Laboratories, Ltd., cleared under FDA 510(k) K123977 on 21 Nov 2013 and listed in FDA GUDID since 16 Sep 2016 (UDI-DI 05055273213973), active as of 22 Oct 2026.

Active United States. Also listed in GUDID (US).

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

510(k) K123977

FDA submission, from GUDID

Trust

Unverified

Source GUDID, synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number05055273213973 UDI-DI Date16 Sep 2016ListedStatusListed GUDID: in commercial distribution
United StatesFDA 510(k)SESE from GUDID Substantially Equivalent · Traditional NumberK123977 Date21 Nov 2013DecidedStatusActive

Official records

Across registries

2 registries list this device

  • FDA 510(k) K123977 decided 21 Nov 2013 Active
  • FDA GUDID UDI-DI 05055273213973 listed 16 Sep 2016 Listed

Timeline

2 dated events

  1. Cleared FDA 510(k) K123977
  2. Listed FDA GUDID 05055273213973

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

GUDID

Trade name
Ck-Mb
Generic name
Creatine kinase myocardial isoenzyme (CKMB) IVD, reagent
Model / Ref / Catalog
CK4043
Primary DI / UDI-DI
05055273213973
510(k) Number
FDA product code
CGS
GMDN term
Creatine kinase myocardial isoenzyme (CKMB) IVD, reagent
Device class
Class II
Regulation number
862.1215
GUDID distribution status
In Commercial Distribution

Similar devices

Other devices filed under FDA product code CGS (Nad Reduction/Nadh Oxidation, Cpk Or Isoenzymes).

Other devices from Randox Laboratories, Ltd.

See all devices from Randox Laboratories, Ltd. →

Properties

  • Single use
  • Prescription use
  • Convenience kit
  • Lot / batch number
  • Expiration date
Other properties (10, all answered No)